Literature DB >> 15900510

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.

David B Wainscott1, Joseph H Krushinski, James E Audia, John M Schaus, John M Zgombick, Virginia L Lucaites, David L Nelson.   

Abstract

[(3)H]LY334370 was developed as a radioligand to study the characteristics of this compound's interaction with the 5-HT(1F) receptor. Monovalent or divalent cations did not enhance the binding of [(3)H]LY334370 to the cloned human 5-HT(1F) receptor. In the presence of MgCl(2), the time to reach equilibrium was approximately 2 h, while in its absence equilibrium was reached in less than 1 h. [(3)H]LY334370 had high affinity for the cloned human 5-HT(1F) receptor (K(d)=0.446 nM) and the 5-HT(1F) receptor in rat brain (K(d)=0.388 nM). The expression density of 5-HT(1F) receptors, as determined by binding to homogenates of cortical regions from rat, was low (B(max)=79.1 fmol/mg protein). There was a statistically significant correlation between the apparent pK(i) for inhibition of [(3)H]LY334370 binding and the pEC(50) for stimulation of [(35)S]GTPgammaS binding to homogenates of cells expressing the cloned human 5-HT(1F) receptor. In addition, there was a statistically significant correlation between the apparent pK(i) for inhibition of [(3)H]LY334370 binding to the cloned human 5-HT(1F) receptor and the pID(50) for inhibition of trigeminal nerve stimulated dural plasma protein extravasation in the guinea pig. The conclusion from these studies is that [(3)H]LY334370 is a high affinity radioligand which can be used for the study of the 5-HT(1F) receptor in rat brain or in cells transformed with the human 5-HT(1F) receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900510     DOI: 10.1007/s00210-005-1035-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Cloning of serotonin 5-HT(1) receptor subtypes from the chimpanzee, gorilla and Rhesus monkey and their agonist-induced guanosine 5'gamma(35)S triphosphate binding.

Authors:  G L Alberts; J F Pregenzer; W B Im; J L Slightom
Journal:  Neurosci Lett       Date:  2000-02-25       Impact factor: 3.046

2.  Molecular cloning and expression of the porcine trigeminal ganglion cDNA encoding a 5-ht(1F) receptor.

Authors:  Pankaj Bhalla; Hari S Sharma; Thierry Wurch; Petrus J Pauwels; Pramod R Saxena
Journal:  Eur J Pharmacol       Date:  2002-02-01       Impact factor: 4.432

3.  How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown.

Authors:  S Swillens
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

4.  G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.

Authors:  D S Dupuis; F C Colpaert; P J Pauwels
Journal:  Br J Pharmacol       Date:  1998-05       Impact factor: 8.739

5.  Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.

Authors:  M D Hall; H Gozlan; M B Emerit; S el Mestikawy; L Pichat; M Hamon
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

6.  Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial.

Authors:  D J Goldstein; K I Roon; W W Offen; N M Ramadan; L A Phebus; K W Johnson; J M Schaus; M D Ferrari
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

7.  [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.

Authors:  C Waeber; M A Moskowitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

8.  Isolation of a mouse "5HT1E-like" serotonin receptor expressed predominantly in hippocampus.

Authors:  N Amlaiky; S Ramboz; U Boschert; J L Plassat; R Hen
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

9.  Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.

Authors:  N Adham; H T Kao; L E Schecter; J Bard; M Olsen; D Urquhart; M Durkin; P R Hartig; R L Weinshank; T A Branchek
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs.

Authors:  K W Johnson; J M Schaus; M M Durkin; J E Audia; S W Kaldor; M E Flaugh; N Adham; J M Zgombick; M L Cohen; T A Branchek; L A Phebus
Journal:  Neuroreport       Date:  1997-07-07       Impact factor: 1.837

View more
  7 in total

1.  [3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain.

Authors:  Virginia L Lucaites; Joseph H Krushinski; John M Schaus; James E Audia; David L Nelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-27       Impact factor: 3.000

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships.

Authors:  Michael T Klein; Małgorzata Dukat; Richard A Glennon; Milt Teitler
Journal:  J Pharmacol Exp Ther       Date:  2011-03-21       Impact factor: 4.030

Review 4.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

Review 5.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

Review 6.  Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.

Authors:  Andrea Negro; Angela Koverech; Paolo Martelletti
Journal:  J Pain Res       Date:  2018-03-08       Impact factor: 3.133

Review 7.  Lasmiditan mechanism of action - review of a selective 5-HT1F agonist.

Authors:  David B Clemow; Kirk W Johnson; Helen M Hochstetler; Michael H Ossipov; Ann M Hake; Andrew M Blumenfeld
Journal:  J Headache Pain       Date:  2020-06-10       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.